Superluminal Medicines raises $65.5M Series B

Superluminal Medicines announced a $65.5M Series B on September 3, 2026. Investors and valuation were not disclosed in Crunchbase's round record; Lounge adds them as they are reported.

0Share to feed

Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.

See plans →Log in

Discussion · 0

Create a free account to join the discussion.

Superluminal Medicines raises $65.5M Series B

Discussion · 0

Source

Deal sheet

More in Venture